Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Human papillomavirus vaccine recombinant nonavalent Merck (Primary)
- Indications Cancer
- Focus Pharmacodynamics
- 28 Jun 2017 Planned primary completion date changed from 1 Feb 2020 to 1 Jan 2020.
- 28 Jun 2017 Status changed from not yet recruiting to recruiting.
- 27 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 12 Sep 2017.